Related Experiment Video
Updated: Jul 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11
Xiao-Xin Sun1, Mu-Shui Dai, Hua Lu
1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine and Simon Cancer Center, Indianapolis, Indiana 46202, USA.
Abstract:
Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G(1) cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.
Insights
Mycophenolate mofetil (MMF) activates the p53 pathway by inhibiting pre-ribosomal RNA synthesis, causing nucleolar stress. This stress leads to p53 activation through ribosomal proteins L5/L11 and MDM2 interaction.
Area of Science:
- Molecular Biology
- Immunology
- Cancer Biology
Background:
- Mycophenolate mofetil (MMF) is an immunosuppressant prodrug of mycophenolic acid (MPA).
- MPA inhibits inosine monophosphate dehydrogenase (IMPDH), depleting guanine nucleotides and causing cell cycle arrest and apoptosis.
- MPA induces p53, but the activation mechanism remains unclear.
Purpose of the Study:
- To elucidate the mechanism of p53 activation by MPA.
- To investigate the role of nucleolar stress and ribosomal proteins in MPA-induced p53 activation.
Main Methods:
- Assessing pre-rRNA synthesis and nucleolar integrity following MPA treatment.
- Analyzing the interaction between MDM2, L5, and L11 proteins.
- Evaluating p53 induction and cell cycle arrest in cells with L5/L11 knockdown.
Main Results:
- MPA treatment inhibited pre-rRNA synthesis and disrupted the nucleolus.
- MPA enhanced the interaction between MDM2 and ribosomal proteins L5/L11.
- Knockdown of L5 or L11 impaired MPA-induced p53 activation and G1 cell cycle arrest.
Conclusions:
- MPA induces p53 activation via nucleolar stress.
- Ribosomal proteins L5 and L11 mediate p53 induction by inhibiting MDM2 in response to nucleolar stress.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules

